首页> 外文期刊>Journal of chemotherapy >Nosocomial Candida krusei fungemia in cancer patients: report of 10 cases and review.
【24h】

Nosocomial Candida krusei fungemia in cancer patients: report of 10 cases and review.

机译:癌症患者的医院念珠菌昆虫肽:10例报告和审查报告。

获取原文
获取原文并翻译 | 示例
       

摘要

The risk factors, therapy and outcome of ten cases of fungemia due to Candida krusei, appearing during the last 10 years in a single national cancer institution, are analyzed. Univariate analyses did not find any specific risk factors in comparison to 51 Candida albicans fungemias appearing at the same institution and with a similar antibiotic policy. Association with prior fluconazole prophylaxis was not confirmed because only one case appeared in a patient previously treated with fluconazole. However, attributable and crude mortality due to C. krusei fungemias was higher than for C. albicans fungemia. The authors review 172 C. krusei fungemias published within the last 10 years to compare with the incidence, therapy and outcome of C. krusei fungemia from our cancer institute.
机译:分析了由于念珠菌Krusei,在一个国家癌症制度的过去10年中出现的念珠菌的危险因素,治疗和结果。 与在同一机构出现的51名念珠菌鉴定和具有相似抗生素政策的51名念珠菌耳虫病的情况下,单变量分析并没有找到任何特定的风险因素。 未确认与先前氟康唑预防的关系,因为在先前用氟康唑处理的患者中仅出现一种情况。 然而,由于C.Krusei核心的归因和原始死亡率高于白醛葡萄糖毒性的C. krusei。 作者审查了在过去10年内发表的172克鲁斯迪真菌,与我们癌症研究所的C.Krusei Fungemia的发病,治疗和结果进行比较。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号